Nick Wykeman

Nick Wykeman

Chief Executive Officer at Bencard Allergie GmbH

Net worth: 23 664 $ as of 29/04/2024

60 year
Health Technology
Commercial Services
Finance

Profile

Nicolas Alexander Ulrich Wykeman is currently a Director at Allergy Therapeutics (UK) Ltd., a Director at Allergy Therapeutics (Holdings) Ltd., a Managing Director at Bencard Allergie GmbH, and a Member of the Institute of Chartered Accountants in England & Wales.
Previously, he served as the Chief Financial Officer & Executive Director at Allergy Therapeutics Plc from 2016 to 2022.
Prior to that, he was the Group Financial Controller at SkyePharma Plc, Deloitte & Touche LLP UK, and Quest International Ltd.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
29/06/2023 651,724 ( 0.01% ) 23 664 $ 29/04/2024

Nick Wykeman active positions

CompaniesPositionStart
Corporate Officer/Principal -
Director/Board Member -
Chief Executive Officer -
Director/Board Member 08/06/2016
All active positions of Nick Wykeman

Former positions of Nick Wykeman

CompaniesPositionEnd
ALLERGY THERAPEUTICS PLC Director of Finance/CFO 29/11/2022
SKYEPHARMA PLC Comptroller/Controller/Auditor 31/07/2015
Comptroller/Controller/Auditor -
Quest International Ltd. Comptroller/Controller/Auditor -
See the detail of Nick Wykeman's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nick Wykeman's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ALLERGY THERAPEUTICS PLC

Health Technology

Private companies7

Health Technology

Commercial Services

Commercial Services

Health Technology

Quest International Ltd.

Finance

Health Technology

See company connections